Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Current report No. 6/2024

Date of preparation: 21.02.2024

Subject: Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Legal basis: Article 56 sec. 1 point 2 of the Public Offering Act – current and periodical information

The Management Board of Captor Therapeutics S.A., based in Wrocław (the "Company"), pursuant to Article 398, Article 399 § 1 in connection with Articles 402¹ and 402² of the Commercial Companies Code, informs that the Extraordinary General Meeting of the Company was convened for 20 March 2024, at 2:00 P.M. and will be held in Wrocław at ul. Klecińska 125 (54-413 Wrocław), in the BETA building.

The Management Board of the Company encloses the following to this report:

1. the full text of the notice with the agenda of the Extraordinary General Meeting (appendix no. 1);

2. draft resolutions to be discussed at the Extraordinary General Meeting of the Company (appendix
no. 2);

3. opinion of the Company's Management Board on authorising the Company's Management Board to increase the Company's share capital within the limits of the authorised and unissued capital with the option to exclude in full the pre-emptive rights of existing shareholders and to amend the Company's Articles of Association in connection with the Company's authorised and unissued capital (appendix no. 3).